Advertisement

The Current Status of Peritoneal Surface Oncology in Saudi Arabia

  • Mohammad AlyamiEmail author
  • Frederic Mercier
  • Thamer Bin Traiki
  • Nora Trabulsi
  • Ihssan Al-Alem
  • Abdulaziz Alzahrani
  • Mashhour Alqannas
  • Khalid Almohaimeed
Original Article

Abstract

Peritoneal carcinomatosis (PC) is a common evolution of abdominal cancers. It may arise from the peritoneum itself (primary) or originate from another type of cancer especially those of gastrointestinal or gynecological origin (secondary). Without aggressive multimodal therapeutic approaches, PC is associated with a poor prognosis. Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have been used to treat PC since 1990. In Saudi Arabia, the first CRS and HIPEC were done in 2008. In 2018, Saudi Arabia population is 32 millions of people and the demand for such procedures has grown up. This article gives outlines of the current status of peritoneal surface oncology in Saudi Arabia and the future perspective.

Keywords

Peritoneal metastasis CRS HIPEC PIPAC 

Notes

Summary

The Saudi Arabia Peritoneal Surface Oncology Group needs more centers and more trained surgeons to cover for the rising demand. The next challenge will be to start the PC registry and start collaborative project between centers.

References

  1. 1.
    Sadeghi B, Arvieux C, Glehen O, Beaujard AC, Rivoire M, Baulieux J, Fontaumard E, Brachet A, Caillot JL, Faure JL, Porcheron J, Peix JL, François Y, Vignal J, Gilly FN (2000) Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer 88(2):358–363CrossRefGoogle Scholar
  2. 2.
    Sugarbaker PH, Cunliffe WJ, Belliveau J, de Bruijn EA, Graves T, Mullins RE, Schlag P (1989) Rationale for integrating early postoperative intraperitoneal chemotherapy into the surgical treatment of gastrointestinal cancer. Semin Oncol 16(4 Suppl 6):83–97Google Scholar
  3. 3.
    Gilly FN, Sayag AC, Carry PY, Braillon GG, James IM, Volloch AA, Panteix GG (1991) Intra-peritoneal chemo-hyperthermia (CHIP): a new therapy in the treatment of the peritoneal seedings. Preliminary report. Int Surg 76(3):164–167Google Scholar
  4. 4.
    Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IHJT, Ceelen WP, Pelz JO, Piso P, González-Moreno S, van der Speeten K, Morris DL (2012) Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 30(20):2449–2456CrossRefGoogle Scholar
  5. 5.
    Yan TD, Deraco M, Baratti D, Kusamura S, Elias D, Glehen O, Gilly FN, Levine EA, Shen P, Mohamed F, Moran BJ, Morris DL, Chua TC, Piso P, Sugarbaker PH (2009) Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol 27(36):6237–6242CrossRefGoogle Scholar
  6. 6.
    Goere D, Malka D, Tzanis D, Gava V, Boige V, Eveno C et al (2013) Is there a possibility of a cure in patients with colorectal peritoneal carcinomatosis amenable to complete cytoreductive surgery and intraperitoneal chemotherapy? Ann Surg 257(6):1065–1071CrossRefGoogle Scholar
  7. 7.
    Chia CS, You B, Decullier E, Vaudoyer D, Lorimier G, Abboud K et al (2016) Patients with peritoneal carcinomatosis from gastric cancer treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: is cure a possibility? Ann Surg Oncol 23(6):1971–1979CrossRefGoogle Scholar
  8. 8.
    Saudi Cancer Registry (2015) Saudi Arabia cancer incidence report 2012. Saudi Cancer Registry, RiyadhGoogle Scholar
  9. 9.
    Al-Hanawi MK (2017) The healthcare system in Saudi Arabia: how can we best move forward with funding to protect equitable and accessible care for all? Int J Healthc 3(2):78CrossRefGoogle Scholar
  10. 10.
    Sebai ZAMW, Al-Zulaibani AA (2001) Health care services in Saudi Arabia: past, present and future. J Family Community Med 8(3):19–23Google Scholar

Copyright information

© Indian Association of Surgical Oncology 2019

Authors and Affiliations

  1. 1.Department of General Surgery and Surgical OncologyKing Faisal Specialist Hospital & Research CenterRiyadhSaudi Arabia
  2. 2.Department of Surgical OncologyCentre Hospitalo-Universitaire de MontrealMontrealCanada
  3. 3.Department of Surgery, King Khalid University HospitalKing Saud UniversityRiyadhSaudi Arabia
  4. 4.Department of SurgeryKing Abdulaziz University HospitalJeddahSaudi Arabia
  5. 5.Department of Surgical OncologyKing Abdullah Medical CityMakkahSaudi Arabia
  6. 6.Department of General SurgeryKing Khalid HospitalNajranSaudi Arabia
  7. 7.Department of Surgical OncologyKing Fahad Medical CityRiyadhSaudi Arabia

Personalised recommendations